Mishima, Japan

Takahiro Motoshiromizu

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.8

ph-index = 1


Location History:

  • Mishima, JP (2020)
  • Kamakura, JP (2023 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Takahiro Motoshiromizu: Innovator in Cerium Oxide Nanoparticles

Introduction

Takahiro Motoshiromizu is a prominent inventor based in Mishima, Japan. He has made significant contributions to the field of nanotechnology, particularly in the development of cerium oxide nanoparticles. With a total of 4 patents to his name, Motoshiromizu's work has implications in various applications, including antioxidants and antifungal agents.

Latest Patents

Motoshiromizu's latest patents focus on the production and application of cerium oxide nanoparticles. One of his notable inventions involves a method for producing cerium oxide nanoparticles by mixing a solution of an aromatic heterocyclic compound with a cerium (III) ion solution or salt, followed by the addition of an oxidant. Another patent describes a cerium oxide nanoparticle whose surface is covered with a vinyl polymer, which can be used in the decomposition of nucleic acids and polypeptides.

Career Highlights

Motoshiromizu is currently employed at Toray Industries, Inc., where he continues to innovate and develop new technologies. His work has garnered attention for its potential applications in various fields, including medicine and materials science.

Collaborations

Motoshiromizu collaborates with talented individuals such as Shota Sekiguchi and Masateru Ito, contributing to a dynamic research environment that fosters innovation.

Conclusion

Takahiro Motoshiromizu is a key figure in the advancement of cerium oxide nanoparticles, with a focus on their production and application. His contributions to the field are paving the way for new technological advancements and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…